Report Details Translational Regenerative Medicine - new study showing you trends, R&D progress, and predicted revenues Where is the market for regenerative medicine heading? What are the commercial prospects for this market and related technologies? Visiongain's brand new report shows you potential revenues and other trends to 2025, discussing data, opportunities and prospects. Visiongain's report lets you assess regenerative medicine: cell-based therapies that aim to restore function and regenerate diseased tissues. Our 260 page report provides 145 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at world market, submarket and national level. You will see financial results, interviews, trends, opportunities and revenue predictions. Forecasts from 2015-2025 and other analyses show you commercial prospects Besides revenue forecasting to 2025, our new study provides you with recent results, growth rates, and market shares. There you will find original analyses, with business outlooks and developments. Discover qualitative analyses (including SWOT and Porter's Five Forces), company profiles and commercial developments. Read the full transcript of an exclusive expert opinion interview from industry specialists informing your understanding and allowing you to assess prospects for investments and sales: Dr … Continue reading →

Bengaluru:Feb 27, 2015, DHNS Two courses of stem cell therapy have helped Ashok Kumar, 59, who suffered from tremors and rigidity due to Parkinsons disease, recover completely, much to the joy of his family. The man was brought inside my cabin in a wheelchair. He was unable to even sit on the chair without support. Today, he walks independently. Stem cell therapy has made it possible for him, said Dr Naseem Sadiq, Director, Plexus Neuro and Stem Cell Research Centre, who began treating Kumar in October, last year. Previously, medication and surgical procedure were the only treatment option for Parkinsons disease. Medication in the long-term often lacks effectiveness and may cause side effects, while surgery is not always feasible. Lately, stem cell therapy has turned out to be a boon for patients with Parkinsons, Dr Sadiq said. Kumar is among the few who have benefited from stem cell therapy. However, though the State has been reporting an increase in the number of registered stem cell donors, it is far behind sufficient as the genetic match between donor and recipient could be anywhere between one in 10,000 and one in two million, according to experts. Speaking to Deccan Herald, Raghu Rajgopal, … Continue reading →

WELCOME TO PROGENCELL-STEM CELL THERAPIES Congratulations on taking the first step to improving your health! PROGENCELL offers stem cell protocols with effective results. Many years of research and experience have resulted in substantial improvements in the health and conditions of patients with various diseases, even where other treatments have failed. With the highest quality protocols, Progencell uses stem cells directly from the patient (autologous adult stem cells) in order to improve their health. The patients medical condition creates the appropriate environment in the body, resulting in a personalized therapy created specially for him. We offer patients with certain degenerative diseases an opportunity to improve their health through cellular therapy, correcting their medical conditions from the source by regenerating the tissues and organs that are causing the ailments. Since we use stem cells from the patient, this therapy has no risk of tissue rejection, and minimal secondary effects. Originally posted here: Progencell | Stem Cell Therapy | Tijuana Mexico … Continue reading →

A team of European researchers has devised a strategy to ensure that adult epidermal stem cells are safe before they are used as treatments for patients. The approach involves a clonal strategy where stem cells are collected and cultivated, genetically modified and single cells isolated before being rigorously tested to make sure they meet the highest possible safety criteria. The strategy, which is published online in EMBO Molecular Medicine, is inspired by the approaches the biotechnology industry and regulatory affairs authorities have adopted for medicinal proteins produced from genetically engineered mammalian cells. "Until now there has not been a systematic way to ensure that adult epidermal stem cells meet all the necessary requirements for safety before use as treatments for disease," says EMBO Member Yann Barrandon, Professor at Lausanne University Hospital, the Swiss Federal Institute of Technology in Lausanne and the lead author of the study. "We have devised a single cell strategy that is sufficiently scalable to assess the viability and safety of adult epidermal stem cells using an array of cell and molecular assays before the cells are used directly for the treatment of patients. We have used this strategy in a proof-of-concept study that involves treatment of … Continue reading →

Riverside, ON and Brea CA (PRWEB) February 26, 2015 The Irvine Stem Cell Treatment Center announces a series of free public seminars on the use of adult stem cells for various degenerative and inflammatory conditions. They will be provided by Dr. Thomas A. Gionis, Surgeon-in-Chief. The seminars will be held on Saturday, March 7, 2015, at 11:00 am, 1:00 pm and 3:00 pm at Courtyard Riverside Downtown / Marriott, 1510 University Avenue, Riverside, CA 92507; Tuesday, March 10, 2015, at 11:00 am, 1:00 pm and 3:00 pm at Ayres Suites Ontario at the Mills Mall, 4370 Mills Circle, Ontario, CA 91764; and Saturday, March 21, 2015, at 11:00 am, 1:00 pm and 3:00 pm at Embassy Suites Hotel, 900 E Birch Street, Brea, CA 92821. Please RSVP at (949) 679-3889. The Irvine Stem Cell Treatment Center (Irvine and Westlake), along with sister affiliates, the Miami Stem Cell Treatment Center (Miami; Boca Raton; Orlando; The Villages, Florida) and the Manhattan Regenerative Medicine Medical Group (Manhattan, New York), abide by approved investigational protocols using adult adipose derived stem cells (ADSCs) which can be deployed to improve patients quality of life for a number of chronic, degenerative and inflammatory conditions and diseases. ADSCs … Continue reading →

Contact Information Available for logged-in reporters only Newswise TAMPA, Fla. Glioblastomas are a highly aggressive type of brain tumor, with few effective treatment options. Moffitt Cancer Center researchers are one step closer to understanding glioblastoma development following the identification of a key protein signaling pathway involved in brain tumor stem cell growth and survival. Brain tumor stem cells are believed to play an important role in glioblastoma development and may be possible therapeutic targets. The neurotrophin protein pathway controls nerve growth, survival and specialization. In an article published in the Feb. 6 issue of The Journal of Biological Chemistry, Moffitt researchers reported that the neurotrophin pathway is also involved in the survival and growth of brain tumor stem cells. The stem cells have high levels of neurotrophin receptors called TrkB and TrkC. Cellular signals from normal brain cells can activate TrkB and TrkC on the stem cells and stimulate cell growth. And when scientists inhibited TrkB and TrkC, they found decreased stem cell survival. This suggests that TrkB and TrkC may be possible drug targets for stem cells in gliomas and glioblastomas. This work might be a first step in developing new treatment approaches targeting brain tumor stem cells. It … Continue reading →